Daily Market Commentary for February 4, 2014
Pfizer Inc. (PFE-NYSE) reported on Monday that their mid-stage trial for their breast cancer treatment Palbociclib, met the study's primary goal.
(read more at:http://www.millennium-traders.com/news/newscommentary.aspx)
Thanks for reading
Millennium-Traders.Com
http://www.millennium-traders.com